Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo-controlled Trial of the Safety and Efficacy of C-1073 (Mifepristone) as Adjunctive Therapy in Alzheimer's Disease

NCT00105105 is registered in ClinicalTrials.gov with Corcept Therapeutics as lead sponsor.

NCT NCT00105105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00105105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo-controlled Trial of the Safety and Efficacy of C-1073 (Mifepristone) as Adjunctive Therapy in Alzheimer's Disease
Lead sponsor
Corcept Therapeutics
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2003
Completion date
November 30, 2005
Enrollment
160
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease